We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$228B
AUM Growth
+$19.5B
Cap. Flow
+$9.66B
Cap. Flow %
4.24%
Top 10 Hldgs %
19.68%
Holding
7,447
New
331
Increased
2,461
Reduced
3,156
Closed
486

Sector Composition

Rank Sector Weight
1 Financials 21.58%
2 Energy 8.65%
3 Industrials 8.54%
4 Technology 7.61%
5 Communication Services 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIFC
6826
AI Financial Corp
AIFC
$58.6M
0
TRAW icon
6827
Traws Pharma
TRAW
$8.12M
0
GRDX
6828
GridAI Technologies Corp
GRDX
$23.3M
0
ATYR
6829
aTyr Pharma
ATYR
$53M
-1
Closed
AIOT
6830
PowerFleet Inc
AIOT
$421M
-9
Closed
ORKA
6831
Oruka Therapeutics
ORKA
$7.11B
0
JCTC
6832
Jewett-Cameron Trading
JCTC
$10.3M
$0 ﹤0.01%
2
AIFU
6833
AIFU Inc
AIFU
$218M
0
GRCE
6834
Grace Therapeutics
GRCE
$44.2M
$0 ﹤0.01%
2
MAGN
6835
Magnera Corp
MAGN
$443M
-395
Closed -$100K
PHLT
6836
DELISTED
Performant Healthcare Inc
PHLT
$0 ﹤0.01%
8
TBCH
6837
Turtle Beach Corp
TBCH
$230M
$0 ﹤0.01%
4
RNTX
6838
Rein Therapeutics
RNTX
$68.9M
-22
Closed -$6K
AAVM
6839
EA Series Trust Alpha Architect Global Factor Equity ETF
AAVM
$27.1M
-3,301
Closed -$90K
SGI
6840
PUT
Somnigroup International
SGI
$13.5B
-50,400
Closed -$813K
TGEN
6841
Tecogen Inc
TGEN
$120M
$0 ﹤0.01%
10
EVBN
6842
DELISTED
Evans Bancorp Inc
EVBN
-407
Closed -$18K
IVAC
6843
DELISTED
Intevac Inc
IVAC
$0 ﹤0.01%
46
-2,885
-98% -$22.1K
SYRS
6844
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$0 ﹤0.01%
3
-104
-97% -$14K
AE
6845
DELISTED
Adams Resources & Energy Inc
AE
$0 ﹤0.01%
13
-152
-92% -$6.76K
PFIE
6846
DELISTED
Profire Energy, Inc
PFIE
$0 ﹤0.01%
21
WHLM
6847
DELISTED
Wilhelmina International, Inc
WHLM
$0 ﹤0.01%
1
AKTS
6848
DELISTED
Akoustis Technologies Inc
AKTS
$0 ﹤0.01%
65
-711
-92% -$4.47K
NTBL
6849
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
0
SEEL
6850
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0

Similar funds

Royal Bank of Canada's Q4 2017 Portfolio in Review

As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.

  • Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
  • Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
  • Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
  • Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
  • Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
  • Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.